Nurse Practitioner in Harlan, IA Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Calla L Poldberg, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1213 Garfield Ave, Harlan, IA 51537 Phone: 712-755-4422 Fax: 712-755-4375 |
Kristine K Gross, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1303 Garfield Ave, Harlan, IA 51537 Phone: 712-755-5056 Fax: 712-755-7143 |
Jean R Stamp, A.R.N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1220 Chatburn Ave, Harlan, IA 51537 Phone: 712-755-5130 Fax: 712-755-4470 |
Sarah Marie Mgonja, A.R.N.P. Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1220 Chatburn Ave, Harlan, IA 51537 Phone: 712-755-5130 Fax: 712-755-4445 |
Amanda Jo Sumner, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1110 Morningview Dr, Harlan, IA 51537 Phone: 712-755-5056 Fax: 712-755-7143 |
News Archive
Patient's personal activity tracker, smartphone can help physicians treat new-onset atrial fibrillation
Emergency physicians used a patient's personal activity tracker and smartphone to identify the time his heart arrhythmia started, which allowed them to treat his new-onset atrial fibrillation with electrical cardioversion and discharge him home.
US model of treating depression could effectively be imported into UK
A US model of treating depression through a network of specialists could effectively be imported into the UK, new research has revealed.
OBI advances Phase IIb clinical trial of Oxycyte for treatment of TBI
Oxygen Biotherapeutics, Inc., ("OBI") (NASDAQ: OXBT), today announced enrollment of the first subject in the second cohort of its global Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte® in patients with severe, non-penetrating traumatic brain injury ("STOP-TBI").
Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program
Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.
Researchers demonstrate direct connection between NOX proteins and liver fibrosis
Researchers at the University of California, San Diego School of Medicine have demonstrated a direct connection between two signaling proteins and liver fibrosis, a scarring process underlying chronic liver disease, the 12th leading cause of death in the United States.
› Verified 5 days ago
Nurse Practitioner
Physician Assistant
Nurse Anesthetist - CR
Registered Nurse